First Part:
Summarizing this article by Codrin link https://www.digitalauthority.me/resources/pharma-marketing-guide/
Second Part:
From the link apply and consider how the communication the company Pharming is currently implementing can be improved. Below is a list of their current communication efforts:
Advisory boards to keep a pulse on the market (especially in light of how competitive the market is and the shifts weve seen over the past few years)
Round table
Consulting
1:1 meetings at conferences (hopefully this will return soon)
White paper engage with HCPs to put together a white paper that can be shared promotionally on a particular topic, e.g. C1-INH, RUCONEST, re-dosing, etc.
Engaging video content engage with HCP(s) to create a video discussing similar topics to the above that can be shared through various channels, e.g. sales, e-mail, website, etc.
Overall:
The Bottom line, the biggest impact on ROI is personal engagement in a face-to-face or virtual meeting even though face-to-face meetings have been greatly challenged by COVID. In rare disease markets, the ability to interact personally is much greater than in non-rare diseases. Any non-personal tactics Pharming deployed for RUCONEST were not as effective.
Use the order calculator below and get started! Contact our live support team for any assistance or inquiry.
[order_calculator]